Page last updated: 2024-11-13

toxin iii (anemonia sulcata)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

toxin III (Anemonia sulcata): polypeptide with 27 amino acid residues; see also record for cytolysin III (Stoichactis helianthus) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID86278616
MeSH IDM0100382

Synonyms (9)

Synonym
rtx-iii
sea anemone toxin iii
toxin iii (anemonia sulcata)
60748-46-1
setoxin iii
neurotoxin rtx iii
atx iii
rtx iii
se toxin iii

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Diacetylated derivatives were 30- to 35-fold less toxic than the native toxin."( Structure-toxicity relationships of neurotoxin RTX-III from the sea anemone Radianthus macrodactylus: modification of amino groups.
Kozlovskaya, EP; Mahnir, VM, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (42.86)18.7374
1990's9 (42.86)18.2507
2000's1 (4.76)29.6817
2010's0 (0.00)24.3611
2020's2 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.52 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]